DT MedTech, LLC

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

Clinical Trials↗

All sponsored trials (all statuses)

Activity

Key Events

Jun 24, 2026TrialPost Approval Study 2: Hintermann Series H3 Total Ankle Replacement System

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Regulatory

Regulatory Timeline

19823 events

FDAJan 1

Tagamet — TAGAMET

Application NDA017920 (NDA)

FDAJan 1

Tagamet — TAGAMET

Application NDA017924 (NDA)

FDAJan 1

Tagamet — TAGAMET

Application NDA017939 (NDA)

19851 event

FDAOct 31

Tagamet — TAGAMET HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

Application NDA019434 (NDA)

19861 event

FDAMar 31

Elimite — NIX

Application NDA019435 (NDA)

19891 event

FDAAug 25

Elimite — ELIMITE

Application NDA019855 (NDA)

19901 event

FDAMay 2

Elimite — NIX

Application NDA019918 (NDA)

19951 event

FDAJun 19

Tagamet — TAGAMET HB

Application NDA020238 (NDA)

19991 event

FDAJul 9

Tagamet — TAGAMET HB 200

Application NDA020951 (NDA)

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)